{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:39:59Z","timestamp":1785281999849,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jaci.2023.03.035","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T17:14:07Z","timestamp":1685034847000},"page":"783-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease"],"prefix":"10.1016","volume":"152","author":[{"given":"Suzanne","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avneet","family":"Manghera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachrissa","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Yager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefin","family":"Rhys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl S.","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryn","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevan","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Al-Mossawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Maroof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.03.035_bib1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","article-title":"Helper T cell differentiation","volume":"16","author":"Saravia","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","article-title":"Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens","volume":"126","author":"Curtis","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2023.03.035_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.03.035_bib4","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.03.035_bib5","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","article-title":"Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides","volume":"58","author":"Jandus","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2023.03.035_bib6","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1093\/emboj\/20.19.5332","article-title":"IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding","volume":"20","author":"Hymowitz","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2023.03.035_bib7","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.4049\/jimmunol.179.11.7791","article-title":"An IL-17F\/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment","volume":"179","author":"Liang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib8","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.03.035_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10273","key":"10.1016\/j.jaci.2023.03.035_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(21)00126-4","article-title":"Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial","volume":"397","author":"Gordon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2023.03.035_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaad.2018.03.037","article-title":"Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial","volume":"72","author":"Papp","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"10222","key":"10.1016\/j.jaci.2023.03.035_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(19)33161-7","article-title":"Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2B trial","volume":"395","author":"Ritchlin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2023.03.035_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/annrheumdis-2020-216980","article-title":"Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study","volume":"79","author":"van der Heijde","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2023.03.035_bib15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jamadermatol.2021.2905","article-title":"Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind, placebo-controlled randomized clinical trial","volume":"157","author":"Glatt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2023.03.035_bib16","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2102388","article-title":"Bimekizumab versus adalimumab in plaque psoriasis","author":"Warren","year":"2021","journal-title":"N Engl J Med"},{"issue":"10273","key":"10.1016\/j.jaci.2023.03.035_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(21)00125-2","article-title":"Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial","volume":"397","author":"Reich","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2023.03.035_bib18","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus secukinumab in plaque psoriasis","author":"Reich","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.03.035_bib19","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1073\/pnas.0600666103","article-title":"Selective regulatory function of Socs3 in the formation of IL-17\u2013secreting T cells","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2023.03.035_bib20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2023.03.035_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2023.03.035_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/eji.201948138","article-title":"Presence, function, and regulation of IL-17F\u2013expressing human CD4+ T cells","volume":"50","author":"Burns","year":"2020","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058966","article-title":"Regulation of IL-17A production is distinct from IL-17F in a primary human cell co-culture model of T cell\u2013mediated B cell activation","volume":"8","author":"Melton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2023.03.035_bib25","unstructured":"Finney HM, Rapecki SE, Wright MJ, inventors. New bispecific format suitable for use in high-through-put screening. Patent WO2015181282A1, 2015."},{"key":"10.1016\/j.jaci.2023.03.035_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1472-6750-13-104","article-title":"Improved workflows for high throughput library preparation using the transposome-based nextera system","volume":"13","author":"Lamble","year":"2013","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.jaci.2023.03.035_bib27","unstructured":"Andrews S. FastQC. Available at: https:\/\/github.com\/s-andrews\/FastQC. Accessed June 8, 2023."},{"key":"10.1016\/j.jaci.2023.03.035_bib28","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2023.03.035_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaci.2023.03.035_bib30","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-Seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.jaci.2023.03.035_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2023.03.035_bib32","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2023.03.035_bib33","unstructured":"Ma C. RGSEA: random gene set enrichment analysis. R package version 1260 2021."},{"key":"10.1016\/j.jaci.2023.03.035_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaci.2023.03.035_bib35","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaci.2023.03.035_bib36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"issue":"7381","key":"10.1016\/j.jaci.2023.03.035_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature10730","article-title":"Differential oestrogen receptor binding is associated with clinical outcome in breast cancer","volume":"481","author":"Ross-Innes","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2023.03.035_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12859-021-04321-2","article-title":"Searchlight: automated bulk RNA-seq exploration and visualisation using dynamically generated R scripts","volume":"22","author":"Cole","year":"2021","journal-title":"BMC Bioinformatics"},{"issue":"6245","key":"10.1016\/j.jaci.2023.03.035_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/342082a0","article-title":"Interleukin-2\u2013dependent autocrine proliferation in T-cell development","volume":"342","author":"Toribio","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2023.03.035_bib40","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jaci.2021.04.021","article-title":"Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets","volume":"148","author":"Kim","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2125.1989.tb05366.x","article-title":"Methylprednisolone pharmacokinetics after intravenous and oral administration","volume":"27","author":"Al-Habet","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2023.03.035_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585134","article-title":"Interleukin (IL)-12 and IL-18 synergize to promote MAIT cell IL-17A and IL-17F production independently of IL-23 signaling","volume":"11","author":"Cole","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"\u03b2-Defensin 2 is a responsive biomarker of IL-17A\u2013driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s13075-014-0426-z","article-title":"Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?","volume":"16","author":"van Baarsen","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2023.03.035_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib46","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archderm.1988.01670120027005","article-title":"Interleukin 2 and psoriasis","volume":"124","author":"Lee","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2023.03.035_bib47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5114\/ada.2016.62838","article-title":"Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?","volume":"33","author":"Lesiak","year":"2016","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jaci.2023.03.035_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/clin.1996.4313","article-title":"Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis","volume":"83","author":"Bonifati","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2023.03.035_bib49","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.4049\/jimmunol.181.6.4089","article-title":"TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice","volume":"181","author":"McKinley","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00109-018-1662-5","article-title":"Expression of IL-17F is associated with non-pathogenic Th17 cells","volume":"96","author":"Wanke","year":"2018","journal-title":"J Mol Med"},{"key":"10.1016\/j.jaci.2023.03.035_bib51","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.immuni.2020.06.022","article-title":"The cytokine IL-17A limits Th17 pathogenicity via a negative feedback loop driven by autocrine induction of IL-24","volume":"53","author":"Chong","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2023.03.035_bib52","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib53","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2023.03.035_bib54","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3389\/fimmu.2019.00722","article-title":"Evaluating STAT5 phosphorylation as a mean to assess T cell proliferation","volume":"10","author":"Bitar","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.03.035_bib55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cyto.2013.05.010","article-title":"The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells","volume":"64","author":"Adamik","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2023.03.035_bib56","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.183.3.901","article-title":"Reversibility of T helper 1 and 2 populations is lost after long-term stimulation","volume":"183","author":"Murphy","year":"1996","journal-title":"J Exp Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923006644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923006644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T23:34:57Z","timestamp":1724801697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923006644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0091674923006644"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.03.035","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}